Ahmed, Nehad J.2020-11-182020-11-182020-05Ahmed Nehad J.. Use of Enoxaparin in Obstetrics and Gynecology Department. Journal of Pharmaceutical Research International. 2020 May; 32(8): 1-52456-91192231-2919http://imsear.searo.who.int/handle/123456789/215988Aims: This study aims to demonstrate the use of enoxaparin in obstetrics and gynecology department in Alkharj.Methodology:This is a retrospective study was conducted in a public hospital in Alkharjcity. The outpatient prescriptions were reviewed to evaluate the prescription patternsof enoxaparin. The data were collected and analyzed using Excel software, the descriptive data were represented by frequencies and percentages. Results:About 86.32% of the prescriptions contain enoxaparin syringe were prescribed for female patients. The majority of enoxaparin prescriptions were from obstetrics & gynecology department (79.48%).Moreover, the majority of enoxaparin prescriptions were prescribed by consultants (62.39%).Conclusion:The result of this study show that enoxaparin was prescribed commonly in the obstetrics and gynecology department for female patients because of its efficacy and safety profile. Enoxaparin is safer than other anticoagulants butstill could cause many adverse effects so it is important to increase the health care professional awareness about its useUseenoxaparinobstetricsgynecologypregnancyJournal ArticleIndiaDepartmentof Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-kharj, Saudi Arabia